ANGIE-KOLLEEN TAN: Open Payments
NPI 1063961324 · PACOIMA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$67,167 in 114 payments from 7 companies in 2025. Trend: 2023 $46,065 · 2024 $33,742 · 2025 $67,167
Speaker / faculty: $58,784Travel & lodging: $5,028Food & beverage: $3,245Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 91 | $63,608 |
| ACADIA Pharmaceuticals Inc | 11 | $2,609 |
| Otsuka America Pharmaceutical, Inc. | 3 | $369 |
| Alpha Cognition USA, Inc. | 5 | $295 |
| E.R. Squibb & Sons, L.L.C. | 1 | $123 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
Products named: AUSTEDO XR, NUPLAZID, Zunveyl, REXULTI, COBENFY, ABILIFY MAINTENA, Auvelity, INGREZZA.
Industry payments across CA — which companies pay providers there.
